2026 US Medical Device & Diagnostic Post-Market Surveillance,
Vigilance & Clinical Evidence Conference
- 24th - 26th March 2026
- US
Testimonials
"Well-organized, interesting, and well-balanced agenda."
Technical Manager Renishaw Neurological Solutions Ltd
"Valuable insights were offered on the most critical changes in MDR, and it was useful to learn how IIS can be used for regulatory purposes. It was a great opportunity to interact with fellow industry members."
Clinical Operations Manager Maquet Critical Care
"Very well organized. There is a great variety of related topics and good interaction opportunities."
Clinical Project Manager Philips
"Networking is a good way to get another external opinion."
Director Clinical Research EU Smith + Nephew
"A small group, but very consistent in profile - medical devices & clinical studies. Exchange was promoted, there were good speakers, and the presence of NB representatives in active discussions was a very good addition."
Vice President Clinical AffairsMicroport
"Having experts from the industry, Notified Bodies, and Authorities is of great value because it provides a forum for an open discussion on requirements, interpretations & implementation."
Director of Clinical Affairs, EMEA COOK MEDICAL
